Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126177881 | 12617788 | 1 | I | 20151115 | 0 | 20160802 | 20160802 | DIR | 38.00 | YR | F | N | 115.00000 | LBS | 20160801 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126177881 | 12617788 | 1 | PS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | N | Y | 0 | QD | ||||||||
| 126177881 | 12617788 | 2 | SS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | Oral | N | Y | 0 | 10 | DF | COATED TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126177881 | 12617788 | 1 | Pneumonia |
| 126177881 | 12617788 | 2 | Pneumonia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126177881 | 12617788 | DS |
| 126177881 | 12617788 | RI |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126177881 | 12617788 | Quality of life decreased | |
| 126177881 | 12617788 | Tendonitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126177881 | 12617788 | 1 | 20151115 | 20151116 | 0 | |
| 126177881 | 12617788 | 2 | 20150816 | 20150825 | 0 |